UMIN ID: UMIN000060985
Registered date:19/03/2026
ZURZUVAE Capsules 30mg Drug Use-results Survey
Basic Information
| Recruitment status | Pending |
|---|---|
| Health condition(s) or Problem(s) studied | Depression or Depressed State |
| Date of first enrollment | 2026/04/30 |
| Target sample size | 1500 |
| Countries of recruitment | Japan |
| Study type | Observational |
| Intervention(s) |
Outcome(s)
| Primary Outcome | Safety Incidence of adverse drug reactions |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | Not applicable |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | NA |
Related Information
| Primary Sponsor | Shionogi & Co., Ltd. |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Shionogi & Co., Ltd. |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Yumina Oiwa |
| Address | GRAND GREEN OSAKA South Building Park Tower, 5-54 Ofuka-cho, Kita-ku, Osaka, 530-0011, Japan 530-0011 |
| Telephone | +81-6-6202-2161 |
| yumina.oiwa@shionogi.co.jp | |
| Affiliation | Shionogi & Co., Ltd. Pharmacovigilance Department |
| scientific contact | |
| Name | Yuka Niimi |
| Address | GRAND GREEN OSAKA South Building Park Tower, 5-54 Ofuka-cho, Kita-ku, Osaka, 530-0011, Japan |
| Telephone | +81-6-6202-2161 |
| yuka.niimi@shionogi.co.jp | |
| Affiliation | Shionogi & Co., Ltd. Pharmacovigilance Department |